The structural basis for the biological specificity of human cystatin C has been investigated. Cystatin C and other inhibitors belonging to family 2 of the cystatin superfamily interact reversibly with target peptidases, seemingly by independent affinity contributions from a wedge-shaped binding region built from two loop-forming inhibitor segments and a binding region corresponding to the N-terminal segment of the inhibitor. Human cystatin C variants with Gly substitutions for residues Arg-8, Leu-9, and/or Val-10 of the N-terminal binding region, and/or the evolutionarily conserved Trp-106 in the wedge-shaped binding region, were produced by site-directed mutagenesis and Escherichia coli expression. A total of 10 variants were isolated, structurally verified, and compared to wild-type cystatin C with respect to inhibition of the mammalian cysteine peptidases, cathepsins B, H, L, and S. Varying contributions from the N-terminal binding region and the wedge-shaped binding region to cystatin C affinity for the four target peptidases were observed. Interactions from the side chains of residues in the N-terminal binding region and Trp-106 are jointly responsible for the major part of cystatin C affinity for cathepsin L and are also of considerable importance for cathepsin B and H affinity. In contrast, for cathepsin S inhibition these interactions are of lesser significance, as reflected by a K value of 10M for the cystatin C variant devoid of Arg-8, Leu-9, Val-10, and Trp-106 side chains. The side chain of Val-10 is responsible for most of the affinity contribution from the N-terminal binding region, for all four enzymes. The contribution of the Arg-8 side chain is minor, but significant for cystatin C interaction with cathepsin B. The Leu-9 side chain confers selectivity to the inhibition of the target peptidases; it contributes to cathepsin B and L affinity by factors of 200 and 50, respectively, to cathepsin S binding by a factor of 5 only, and results in a 10-fold decreased affinity between cystatin C and cathepsin H.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				I. Redzynia, A. Ljunggren, M. Abrahamson, J. S. Mort, J. C. Krupa, M. Jaskolski, and G. Bujacz Displacement of the Occluding Loop by the Parasite Protein, Chagasin, Results in Efficient Inhibition of Human Cathepsin B J. Biol. Chem., August 15, 2008; 283(33): 22815 - 22825. [Abstract] [Full Text] [PDF]

				A. Wehner, K. Hartmann, and J. Hirschberger Utility of Serum Cystatin C as a Clinical Measure of Renal Function in Dogs J. Am. Anim. Hosp. Assoc., May 1, 2008; 44(3): 131 - 138. [Abstract] [Full Text] [PDF]

				S. Mukherjee, A. Ukil, and P. K. Das Immunomodulatory Peptide from Cystatin, a Natural Cysteine Protease Inhibitor, against Leishmaniasis as a Model Macrophage Disease Antimicrob. Agents Chemother., May 1, 2007; 51(5): 1700 - 1707. [Abstract] [Full Text] [PDF]

				G. Song, T. E. Spencer, and F. W. Bazer Progesterone and Interferon-{tau} Regulate Cystatin C in the Endometrium Endocrinology, July 1, 2006; 147(7): 3478 - 3483. [Abstract] [Full Text] [PDF]

				M. Alvarez-Fernandez, Y.-H. Liang, M. Abrahamson, and X.-D. Su Crystal Structure of Human Cystatin D, a Cysteine Peptidase Inhibitor with Restricted Inhibition Profile J. Biol. Chem., May 6, 2005; 280(18): 18221 - 18228. [Abstract] [Full Text] [PDF]

				P. Schierack, R. Lucius, B. Sonnenburg, K. Schilling, and S. Hartmann Parasite-Specific Immunomodulatory Functions of Filarial Cystatin Infect. Immun., May 1, 2003; 71(5): 2422 - 2429. [Abstract] [Full Text] [PDF]

				D.P. Dickinson SALIVARY (SD-TYPE) CYSTATINS: OVER ONE BILLION YEARS IN THE MAKING--BUT TO WHAT PURPOSE? Crit. Rev. Oral. Biol. Med., November 1, 2002; 13(6): 485 - 508. [Abstract] [Full Text] [PDF]

				K. G. Hamil, Q. Liu, P. Sivashanmugam, S. Yenugu, R. Soundararajan, G. Grossman, R. T. Richardson, Y.-L. Zhang, M. G. O'Rand, P. Petrusz, et al. Cystatin 11: A New Member of the Cystatin Type 2 Family Endocrinology, July 1, 2002; 143(7): 2787 - 2796. [Abstract] [Full Text] [PDF]

				A. Schonemeyer, R. Lucius, B. Sonnenburg, N. Brattig, R. Sabat, K. Schilling, J. Bradley, and S. Hartmann Modulation of Human T Cell Responses and Macrophage Functions by Onchocystatin, a Secreted Protein of the Filarial Nematode Onchocerca volvulus J. Immunol., September 15, 2001; 167(6): 3207 - 3215. [Abstract] [Full Text] [PDF]

				M. Alvarez-Fernandez, A. J. Barrett, B. Gerhartz, P. M. Dando, J. Ni, and M. Abrahamson Inhibition of Mammalian Legumain by Some Cystatins Is Due to a Novel Second Reactive Site J. Biol. Chem., July 2, 1999; 274(27): 19195 - 19203. [Abstract] [Full Text] [PDF]

				M. Morita, N. Yoshiuchi, H. Arakawa, and S. Nishimura CMAP: A Novel Cystatin-like Gene Involved in Liver Metastasis Cancer Res., January 1, 1999; 59(1): 151 - 158. [Abstract] [Full Text] [PDF]

				J. Ni, M. A. Fernandez, L. Danielsson, R. A. Chillakuru, J. Zhang, A. Grubb, J. Su, R. Gentz, and M. Abrahamson Cystatin F Is a Glycosylated Human Low Molecular Weight Cysteine Proteinase Inhibitor J. Biol. Chem., September 18, 1998; 273(38): 24797 - 24804. [Abstract] [Full Text] [PDF]

				S. Halfon, J. Ford, J. Foster, L. Dowling, L. Lucian, M. Sterling, Y. Xu, M. Weiss, M. Ikeda, D. Liggett, et al. Leukocystatin, A New Class II Cystatin Expressed Selectively by Hematopoietic Cells J. Biol. Chem., June 26, 1998; 273(26): 16400 - 16408. [Abstract] [Full Text] [PDF]

				J. Ni, M. Abrahamson, M. Zhang, M. A. Fernandez, A. Grubb, J. Su, G.-L. Yu, Y. Li, D. Parmelee, L. Xing, et al. Cystatin E is a Novel Human Cysteine Proteinase Inhibitor with Structural Resemblance to Family 2Cystatins J. Biol. Chem., April 18, 1997; 272(16): 10853 - 10858. [Abstract] [Full Text] [PDF]

				G. Sotiropoulou, A. Anisowicz, and R. Sager Identification, Cloning, and Characterization of Cystatin M, a Novel Cysteine Proteinase Inhibitor, Down-regulated in Breast Cancer J. Biol. Chem., January 10, 1997; 272(2): 903 - 910. [Abstract] [Full Text] [PDF]

				I. Ekiel and M. Abrahamson Folding-related Dimerization of Human Cystatin C J. Biol. Chem., January 19, 1996; 271(3): 1314 - 1321. [Abstract] [Full Text] [PDF]